Gregory Sullivan
2022
In 2022, Gregory Sullivan earned a total compensation of $1.5M as Chief Medical Officer at Tonix Pharmaceuticals Holding, a 34% decrease compared to previous year.
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Option Awards | $887,541 |
| Salary | $461,120 |
| Total | $1,478,661 |
Sullivan received $887.5K in option awards, accounting for 60% of the total pay in 2022.
Sullivan also received $130K in bonus and $461.1K in salary.
Rankings
In 2022, Gregory Sullivan's compensation ranked 2,248th out of 5,672 executives tracked by ExecPay. In other words, Sullivan earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,248 out of 5,672 | 60th |
Division Manufacturing | 1,215 out of 3,081 | 61st |
Major group Chemicals And Allied Products | 533 out of 1,396 | 62nd |
Industry group Drugs | 489 out of 1,297 | 62nd |
Industry Pharmaceutical Preparations | 353 out of 940 | 62nd |
Source: SEC filing on March 17, 2023.
Sullivan's colleagues
We found three more compensation records of executives who worked with Gregory Sullivan at Tonix Pharmaceuticals Holding in 2022.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019